Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 07 September, 2024
Author: Getaka|Social: Getaka Financial Services X (Earlier Twitter) Profile Getaka Financial Services LinkedIn Logo
Stock Ticker - BSE: 524640 | NSE: ARCHITORG

Fundamental Analysis of Archit Organosys Ltd

Share Price and Basic Stock Data

Last Updated: September 6, 2024, 10:40 pm

Market Cap 98.9 Cr.
Current Price 48.2
High / Low63.6/35.1
Stock P/E1,412
Book Value 31.3
Dividend Yield1.04 %
ROCE3.69 %
ROE0.75 %
Face Value 10.0
PEG Ratio-83.33

Data Source: screener.in

Stock P/E, Current Price, and Intrinsic Value Over Time

Competitors of Archit Organosys Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Elantas Beck India Ltd 9,406 Cr. 11,86112,998/6,44562.5 1,0180.04 %27.7 %20.6 % 10.0
Crestchem Ltd 48.5 Cr. 162180/60.419.3 16.30.31 %78.2 %56.2 % 10.0
Chemiesynth (Vapi) Ltd 10.5 Cr. 34.134.1/22.0 36.90.00 %1.00 %3.38 % 10.0
Sanginita Chemicals Ltd 41.9 Cr. 16.236.7/15.057.4 15.80.00 %5.18 %1.90 % 10.0
Oriental Aromatics Ltd 1,711 Cr. 510573/29365.5 1880.10 %4.07 %1.45 % 5.00
Industry Average8,664.33 Cr2,392.57162.13313.860.35%18.65%13.80%8.00

Quarterly Result

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Sales30.5128.6742.9638.7426.2930.3528.4622.4246.5531.0026.3924.8130.99
Expenses27.6524.0838.4635.6221.8523.1823.2318.8343.6327.7624.2823.7130.70
Operating Profit2.864.594.503.124.447.175.233.592.923.242.111.100.29
OPM %9.37%16.01%10.47%8.05%16.89%23.62%18.38%16.01%6.27%10.45%8.00%4.43%0.94%
Other Income0.140.040.161.300.420.210.171.841.350.710.540.524.11
Interest0.870.580.550.650.670.860.320.520.500.520.650.770.64
Depreciation0.911.141.171.141.231.201.171.311.171.191.491.491.48
Profit before tax1.222.912.942.632.965.323.913.602.602.240.51-0.642.28
Tax %-30.33%-0.34%52.04%22.81%36.49%22.56%21.74%37.78%22.69%26.79%27.45%-29.69%21.49%
Net Profit1.592.921.412.031.874.123.062.242.011.640.37-0.461.79
EPS in Rs1.061.420.690.990.912.011.491.090.980.800.18-0.220.87

Last Updated: September 7, 2024, 11:53 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: August 24, 2024, 9:46 am

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales384956514882847795138128113109
Expenses374753484478877383121108106103
Operating Profit122344-3411172077
OPM %4%5%4%6%8%5%-4%5%12%12%15%6%6%
Other Income1-011033201366
Interest1111144332233
Depreciation0000133345566
Profit before tax111230-6-15111544
Tax %24%33%43%37%42%-32%-25%1%-7%28%26%24%
Net Profit111121-5-1581133
EPS in Rs0.550.650.870.971.140.34-3.14-0.533.344.015.571.631.32
Dividend Payout %0%0%0%0%0%0%0%0%15%19%9%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)0.00%0.00%0.00%100.00%-50.00%-600.00%80.00%600.00%60.00%37.50%-72.73%
Change in YoY Net Profit Growth (%)0.00%0.00%0.00%100.00%-150.00%-550.00%680.00%520.00%-540.00%-22.50%-110.23%

Growth

Compounded Sales Growth
10 Years:9%
5 Years:6%
3 Years:6%
TTM:-11%
Compounded Profit Growth
10 Years:-2%
5 Years:17%
3 Years:-46%
TTM:-92%
Stock Price CAGR
10 Years:24%
5 Years:47%
3 Years:5%
1 Year:-7%
Return on Equity
10 Years:7%
5 Years:10%
3 Years:12%
Last Year:1%

Last Updated: August 2, 2024, 4:52 pm

Ambani Organics Ltd Balance Sheet

Last Updated: July 10, 2024, 10:19 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Equity Capital33351015151515212121
Reserves12281725201924314144
Borrowings779113136373330343126
Other Liabilities591081226121618182918
Total Liabilities1621243270101848387104122108
Fixed Assets55664747475048455060
CWIP-0-0081851313141
Investments-0-0-0-0-0-0-0-00146
Other Assets111618182246323237445542
Total Assets1621243270101848387104122108

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity 21212-43811111710
Cash from Investing Activity -0-0-2-8-35-91-1-3-12-11-2
Cash from Financing Activity -4-01732130-9-72-6-9
Net Cash Flow-200-0-004-212-0-1

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-6.00-5.00-7.00-8.00-27.00-32.00-40.00-29.00-19.00-17.00-11.00-19.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days841017679861406294977210772
Inventory Days171028282741302221221616
Days Payable58807263801265588875110163
Cash Conversion Cycle443133443356382830442225
Working Capital Days625147585449362956545968
ROCE %15%19%20%17%9%6%-4%3%12%18%17%4%

Financial Efficiency Indicators Chart

Ambani Organics Ltd Share Holding Pattern

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Promoters57.40%57.40%57.40%57.40%57.40%59.83%61.64%62.37%62.37%62.37%62.37%63.26%
Public42.60%42.60%42.60%42.60%42.60%40.17%38.36%37.63%37.63%37.63%37.62%36.74%
No. of Shareholders7,6367,7347,6477,7028,4079,1089,6089,6689,74811,59711,40911,298

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)1.635.574.013.33-0.53
Diluted EPS (Rs.)1.635.574.243.33-0.53
Cash EPS (Rs.)4.387.926.295.771.78
Book Value[Excl.RevalReserv]/Share (Rs.)31.2630.1425.2926.9922.71
Book Value[Incl.RevalReserv]/Share (Rs.)31.2630.1425.2926.9922.71
Dividend / Share (Rs.)0.000.500.750.500.00
Revenue From Operations / Share (Rs.)55.1662.2766.6062.9251.06
PBDIT / Share (Rs.)4.5110.159.047.723.88
PBIT / Share (Rs.)1.757.796.765.281.57
PBT / Share (Rs.)2.147.525.573.12-0.52
Net Profit / Share (Rs.)1.635.574.013.33-0.53
PBDIT Margin (%)8.1716.2913.5712.267.61
PBIT Margin (%)3.1712.5110.148.383.07
PBT Margin (%)3.8712.078.364.95-1.03
Net Profit Margin (%)2.948.946.025.29-1.04
Return on Networth / Equity (%)5.2018.4715.8612.35-2.34
Return on Capital Employeed (%)4.8520.4121.0214.904.96
Return On Assets (%)3.089.337.945.72-0.96
Long Term Debt / Equity (X)0.110.220.230.290.36
Total Debt / Equity (X)0.400.500.610.530.78
Asset Turnover Ratio (%)0.981.131.431.110.91
Current Ratio (X)1.211.201.140.990.85
Quick Ratio (X)1.111.130.980.890.75
Inventory Turnover Ratio (X)10.108.4211.418.986.09
Dividend Payout Ratio (NP) (%)0.0013.4612.460.000.00
Dividend Payout Ratio (CP) (%)0.009.467.940.000.00
Earning Retention Ratio (%)0.0086.5487.540.000.00
Cash Earning Retention Ratio (%)0.0090.5492.060.000.00
Interest Coverage Ratio (X)3.599.437.603.571.85
Interest Coverage Ratio (Post Tax) (X)0.985.434.372.540.74
Enterprise Value (Cr.)110.21149.75106.9055.0632.47
EV / Net Operating Revenue (X)0.971.170.780.580.42
EV / EBITDA (X)11.917.195.764.755.56
MarketCap / Net Operating Revenue (X)0.780.960.580.390.11
Retention Ratios (%)0.0086.5387.530.000.00
Price / BV (X)1.382.001.540.910.25
Price / Net Operating Revenue (X)0.780.960.580.390.11
EarningsYield0.030.090.100.13-0.09

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value: ₹334.91

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 594.83% compared to the current price ₹48.20

Intrinsic Value: 278.16

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 477.10% compared to the current price ₹48.20

Last 5 Year EPS CAGR: -16.95%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has shown consistent growth in sales (82.15 cr) and profit (3.08 cr) over the years.
  1. The stock has a low average ROCE of 11.33%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 51.92, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 35.67, which may not be favorable.
  4. The company has higher borrowings (24.33) compared to reserves (19.50), which may suggest financial risk.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Archit Organosys Ltd:
    1. Net Profit Margin: 2.94%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 4.85% (Industry Average ROCE: 17.39%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 5.2% (Industry Average ROE: 13.05%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 0.98
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.11
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 1 (Industry average Stock P/E: 138.96)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.4
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Archit Organosys Ltd. is a Public Limited Listed company incorporated on 04/08/1993 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1993PLC019941 and registration number is 019941. Currently company belongs to the Industry of Chemicals - Organic - Others. Company’s Total Operating Revenue is Rs. 136.66 Cr. and Equity Capital is Rs. 20.52 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Chemicals - Organic - Others9th Floor, Venus Benecia, Ahmedabad Gujarat 380054share@architorg.com
http://www.architorg.com
Management
NamePosition Held
Mr. Kandarp AminChairman & Wholetime Director
Mr. Archit AminWhole Time Director
Mrs. Archana AminWhole Time Director
Mr. Nikul PatelIndependent Director
Mr. Shreeraj DesaiIndependent Director
Mr. Bhavin ShahIndependent Director
Mr. Vatsal VoraIndependent Director

FAQ

What is the latest fair value of Archit Organosys Ltd?

The latest fair value of Archit Organosys Ltd is ₹334.91.

What is the Market Cap of Archit Organosys Ltd?

The Market Cap of Archit Organosys Ltd is 98.9 Cr..

What is the current Stock Price of Archit Organosys Ltd as on 07 September 2024?

The current stock price of Archit Organosys Ltd as on 07 September 2024 is 48.2.

What is the High / Low of Archit Organosys Ltd stocks in FY 2024?

In FY 2024, the High / Low of Archit Organosys Ltd stocks is 63.6/35.1.

What is the Stock P/E of Archit Organosys Ltd?

The Stock P/E of Archit Organosys Ltd is 1,412.

What is the Book Value of Archit Organosys Ltd?

The Book Value of Archit Organosys Ltd is 31.3.

What is the Dividend Yield of Archit Organosys Ltd?

The Dividend Yield of Archit Organosys Ltd is 1.04 %.

What is the ROCE of Archit Organosys Ltd?

The ROCE of Archit Organosys Ltd is 3.69 %.

What is the ROE of Archit Organosys Ltd?

The ROE of Archit Organosys Ltd is 0.75 %.

What is the Face Value of Archit Organosys Ltd?

The Face Value of Archit Organosys Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Archit Organosys Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE